| Date Filed | Type | Description |
| 10/04/2023 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on NeuroPace Inc|
Txns:
| Sold 7,614 shares
@ $9.08, valued at
$69.1k
Sold 700 shares
@ $9.02, valued at
$6.3k
|
|
| 10/04/2023 |
SC 13D/A
| ORBIMED ADVISORS LLC reports a 4.7% stake in Synlogic, Inc. |
| 10/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 10/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 10/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 10/02/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/23/2023 |
SC 13D/A
| ORBIMED ADVISORS LLC reports a 13.5% stake in PMV Pharmaceuticals, Inc. |
| 08/21/2023 |
144/A
| Form 144/A - Report of proposed sale of securities: [Amend] |
| 08/21/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/21/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/17/2023 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Galecto, Inc.|
Txns:
| Sold 38,327 shares
@ $0.75, valued at
$28.7k
Sold 248,819 shares
@ $0.75, valued at
$186.6k
Sold 535,534 shares
@ $0.75, valued at
$401.7k
|
|
| 08/17/2023 |
SC 13D/A
| ORBIMED ADVISORS LLC reports a 5.9% stake in Galecto, Inc. |
| 08/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/11/2023 |
SC 13D/A
| ORBIMED ADVISORS LLC reports a 8% stake in Gracell Biotechnologies Inc. |
| 08/03/2023 |
SC 13D/A
| ORBIMED ADVISORS LLC reports a 56.7% stake in Xtant Medical Holdings, Inc. |
| 08/02/2023 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Galecto, Inc.|
Txns:
| Sold 26,622 shares
@ $3, valued at
$79.9k
Sold 29,700 shares
@ $3, valued at
$89.1k
Sold 153,078 shares
@ $3, valued at
$459.2k
|
|
| 08/02/2023 |
SC 13D/A
| ORBIMED ADVISORS LLC reports a 8.3% stake in Galecto, Inc. |
| 07/31/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/31/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/27/2023 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Galecto, Inc.|
Txns:
| Sold 7,800 shares
@ $2.92, valued at
$22.8k
Sold 4,700 shares
@ $2.92, valued at
$13.7k
Sold 26,700 shares
@ $2.92, valued at
$78k
|
|
| 07/25/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/25/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/24/2023 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 07/20/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/17/2023 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Galecto, Inc.|
Txns:
| Sold 9,800 shares
@ $2.4, valued at
$23.5k
Sold 52,800 shares
@ $2.4, valued at
$126.7k
Sold 132,100 shares
@ $2.4, valued at
$317k
|
|
| 07/17/2023 |
SC 13D/A
| ORBIMED ADVISORS LLC reports a 9.6% stake in Galecto, Inc. |
| 07/13/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/13/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/29/2023 |
4
| ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Adicet Bio, Inc.|
Txns:
| Bought 125,000 shares
@ $2.09, valued at
$261.3k
Bought 250,000 shares
@ $2.09, valued at
$522.5k
Bought 442,000 shares
@ $2.09, valued at
$923.8k
Bought 58,000 shares
@ $2.09, valued at
$121.2k
|
|
|